FAS and lung carcinoma: The engagement of Fas/FasL interaction in the phenomenon of escape strategy has been reported in many types of malignancies, including hepatocellular carcinoma (57), endometrial cancer (58), leukemic cells (59, 60), and lung cancer (61).